Therefore, a plausible hypothesis is that mutations in these genes—in particular HRAS, EGFR, and RB1—were coincidental findings in individual tumours, and are not recurrent driver events in EP tumourigenesis. The gene discussed is HRAS; the disease is neoplasm.